EG18213A - Pharmaceutical formulation for the treatment of bacterial infections - Google Patents

Pharmaceutical formulation for the treatment of bacterial infections

Info

Publication number
EG18213A
EG18213A EG452/87A EG32087A EG18213A EG 18213 A EG18213 A EG 18213A EG 452/87 A EG452/87 A EG 452/87A EG 32087 A EG32087 A EG 32087A EG 18213 A EG18213 A EG 18213A
Authority
EG
Egypt
Prior art keywords
treatment
pharmaceutical formulation
bacterial infections
infections
bacterial
Prior art date
Application number
EG452/87A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of EG18213A publication Critical patent/EG18213A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cephalosporin Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EG452/87A 1986-06-04 1987-06-02 Pharmaceutical formulation for the treatment of bacterial infections EG18213A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863618813 DE3618813A1 (de) 1986-06-04 1986-06-04 Pharmazeutische zubereitung zur behandlung bakterieller infektionen

Publications (1)

Publication Number Publication Date
EG18213A true EG18213A (en) 1992-09-30

Family

ID=6302277

Family Applications (1)

Application Number Title Priority Date Filing Date
EG452/87A EG18213A (en) 1986-06-04 1987-06-02 Pharmaceutical formulation for the treatment of bacterial infections

Country Status (27)

Country Link
US (1) US4919932A (xx)
EP (1) EP0248361B1 (xx)
JP (1) JPS62292721A (xx)
CN (1) CN87104023A (xx)
AR (1) AR241305A1 (xx)
AT (1) ATE71299T1 (xx)
AU (1) AU597068B2 (xx)
CA (1) CA1294217C (xx)
DD (1) DD257015A5 (xx)
DE (2) DE3618813A1 (xx)
DK (1) DK166759B1 (xx)
EG (1) EG18213A (xx)
ES (1) ES2035829T3 (xx)
FI (1) FI872459A (xx)
GR (1) GR3003856T3 (xx)
HU (1) HU199288B (xx)
IL (1) IL82767A (xx)
MA (1) MA20994A1 (xx)
MY (1) MY101079A (xx)
NO (1) NO872331L (xx)
NZ (1) NZ220509A (xx)
OA (1) OA08609A (xx)
PH (1) PH26214A (xx)
PL (1) PL266058A1 (xx)
PT (1) PT84996B (xx)
TN (1) TNSN87077A1 (xx)
ZA (1) ZA873970B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1231487B (it) * 1988-10-24 1991-12-07 Erba Carlo Spa Composizione sinergica antibatterica contenente penem e ceftizoximaf
EP0384410B1 (en) * 1989-02-21 1995-05-17 Banyu Pharmaceutical Co., Ltd. Antimicrobial composition
DE3909056A1 (de) * 1989-03-18 1990-09-20 Hoechst Ag Pharmazeutische kombinationspraeparate und deren verwendung zur prophylaxe oder behandlung bakterieller infektionskrankheiten
US7491263B2 (en) * 2004-04-05 2009-02-17 Technology Innovation, Llc Storage assembly

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54126735A (en) * 1978-03-24 1979-10-02 Toyama Chem Co Ltd Bactericidal composition for medical use
DE3176517D1 (en) * 1980-04-24 1987-12-17 Beecham Group Plc Beta-lactam compounds, their preparation and use
ES513672A0 (es) * 1981-07-08 1983-04-01 Hoechst Uk Ltd "procedimiento para la preparacion de derivados de penem".
EP0120613A1 (en) * 1983-03-02 1984-10-03 Beecham Group Plc Penem derivatives and precursors
DE3424144A1 (de) * 1984-06-30 1986-01-09 Bayer Ag, 5090 Leverkusen Verfahren zur erhoehung der bruchfestigkeit von granalien

Also Published As

Publication number Publication date
HU199288B (en) 1990-02-28
EP0248361B1 (de) 1992-01-08
PT84996B (pt) 1990-03-08
AR241305A1 (es) 1992-05-29
NO872331L (no) 1987-12-07
AU597068B2 (en) 1990-05-24
CN87104023A (zh) 1988-03-09
PH26214A (en) 1992-03-18
HUT44926A (en) 1988-05-30
NO872331D0 (no) 1987-06-03
OA08609A (fr) 1988-11-30
MA20994A1 (fr) 1987-12-31
MY101079A (en) 1991-07-16
DK166759B1 (da) 1993-07-12
FI872459A0 (fi) 1987-06-02
EP0248361A3 (en) 1989-09-06
AU7379587A (en) 1987-12-10
CA1294217C (en) 1992-01-14
EP0248361A2 (de) 1987-12-09
FI872459A (fi) 1987-12-05
DE3618813A1 (de) 1987-12-10
GR3003856T3 (xx) 1993-03-16
DE3775823D1 (de) 1992-02-20
DD257015A5 (de) 1988-06-01
IL82767A (en) 1992-09-06
ZA873970B (en) 1987-12-02
ES2035829T3 (es) 1993-05-01
IL82767A0 (en) 1987-12-20
JPS62292721A (ja) 1987-12-19
ATE71299T1 (de) 1992-01-15
PT84996A (de) 1987-07-01
DK284787A (da) 1987-12-05
PL266058A1 (en) 1988-07-21
DK284787D0 (da) 1987-06-03
NZ220509A (en) 1989-11-28
US4919932A (en) 1990-04-24
TNSN87077A1 (fr) 1990-01-01

Similar Documents

Publication Publication Date Title
GB2188844B (en) Pharmaceutical composition for the treatment of psoriasis
AU590403B2 (en) Pharmaceutical composition for the treatment of periodontal diseases
IL86089A (en) Pharmaceutical compositions containing certain androstane-17-ones for the prophylaxis and therapy of retroviral infections
GB8706872D0 (en) Prophylactic/therapeutic treatment of bacterial infections
AU550675B2 (en) Pharmaceutical compositions for the treatment of skin
GB2187953B (en) Pharmaceutical formulation
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
IL93242A0 (en) Pharmaceutical preparation for the treatment of tonsillitis
GR3000306T3 (en) Composition for the treatment of infections
ZA876048B (en) Pharmaceutical formulation
IL84550A (en) Pharmaceutical compositions for treatment of viral infections containing 3( -fluoro-3(-deoxy-thymidine
GB8630419D0 (en) Pharmaceutical formulation
IL89057A0 (en) Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives
IL84012A0 (en) Pharmaceutical composition for the treatment of high blood pressure
IE871465L (en) Treatment of bacterial infections
IL82376A (en) Pharmaceutical composition for the treatment of inflammatory conditions
IE862553L (en) Pharmaceutical compositions for treatment gastrointestinal¹disorders
GB8709861D0 (en) Pharmaceutical compositions & treatment
GB8709860D0 (en) Pharmaceutical compositions & treatment
GB8709862D0 (en) Pharmaceutical compositions & treatment
RO92740B1 (ro) Compozitie medicamentoasa pentru tratamentul otitelor
ZA867410B (en) Pharmaceutical composition for the treatment of leukopenia
BG51951B2 (en) Medicamentous form for the treatment of gynaecological infections
GB9305040D0 (en) Preparation for the treatment of virus-induced cutaneous infections
GB8622482D0 (en) Pharmaceutical formulation